NL-OMON32608
已完成
不适用
Dyadic coping with renal transplant and renal disease - DCRT
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- kidney disease
- 发起方
- niversitair Medisch Centrum Groningen
- 入组人数
- 900
- 状态
- 已完成
- 最后更新
- 去年
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patients who have undergone renal transplantation at the UMCG during the past 15 years and their partners will be included in the study. Patients and partners have to be at least 18 years of age at the first assessment. The study is open to both men and women and all ethnic groups as long as participants are in command of the Dutch language.
排除标准
- •As blind patients and partners will not be able to read the questionnaires, they will be excluded.
结局指标
主要结局
未指定
相似试验
进行中（未招募）
不适用
Multidisciplinary Support To Access Living Donor Kidney Transplant-PilotLiving Donor Kidney TransplantationNCT04666545University of Alberta38
已完成
不适用
Retrospective Study: Long-term Health of Living Kidney DonorsKidney DiseasesNCT00319527Lawson Health Research Institute311
进行中（未招募）
不适用
Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT)Living Donor Kidney TransplantationNCT05459337University of Alberta66
已完成
3 期
Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal DysfunctionRenal InsufficiencyNCT01453218Hospital Vall d'Hebron30
已完成
4 期
The aDOPT Trial (Dose Optimisation Prior to Transplant):In kidney transplantation, can pre-transplant blood levels of mycophenolic acid (MPA) help to optimise individual patient's post-transplant mycophenolate mofetil (MMF) dose to improve outcomes?End-stage kidney diseaseKidney transplantationAcute transplant rejectionDrug toxicityRenal and Urogenital - Kidney diseaseInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12615000273583Murdoch Children's Research Institute56